CA2314821A1 - Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells - Google Patents
Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells Download PDFInfo
- Publication number
- CA2314821A1 CA2314821A1 CA002314821A CA2314821A CA2314821A1 CA 2314821 A1 CA2314821 A1 CA 2314821A1 CA 002314821 A CA002314821 A CA 002314821A CA 2314821 A CA2314821 A CA 2314821A CA 2314821 A1 CA2314821 A1 CA 2314821A1
- Authority
- CA
- Canada
- Prior art keywords
- morphogen
- bmp
- phenotype
- cell
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6993197P | 1997-12-17 | 1997-12-17 | |
US11049898P | 1998-12-01 | 1998-12-01 | |
US60/069,931 | 1998-12-01 | ||
US60/110,498 | 1998-12-01 | ||
PCT/US1998/026788 WO1999031136A2 (en) | 1997-12-17 | 1998-12-16 | Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2314821A1 true CA2314821A1 (en) | 1999-06-24 |
Family
ID=26750579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002314821A Abandoned CA2314821A1 (en) | 1997-12-17 | 1998-12-16 | Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1040126A2 (ja) |
JP (1) | JP2002508173A (ja) |
AU (2) | AU763488B2 (ja) |
CA (1) | CA2314821A1 (ja) |
WO (1) | WO1999031136A2 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69714035T2 (de) | 1997-08-14 | 2003-03-06 | Sulzer Innotec Ag | Zusammensetzung und Vorrichtung zur Reparatur von Knorpelgewebe in vivo bestehend aus Nanokapseln mit osteoinduktiven und/oder chondroinduktiven Faktoren |
US6992066B2 (en) | 1998-10-16 | 2006-01-31 | Zimmer Orthobiologics, Inc. | Povidone-containing carriers for polypeptide growth factors |
US7087577B2 (en) | 1998-10-16 | 2006-08-08 | Zimmer Orthobiologies, Inc. | Method of promoting natural bypass |
US20020173453A1 (en) * | 2000-12-15 | 2002-11-21 | Rama Akella | Method of treating renal injury |
US7232802B2 (en) | 2001-12-21 | 2007-06-19 | Zimmer Orthobiologics, Inc. | Compositions and methods for promoting myocardial and peripheral angiogenesis |
CN114470162B (zh) * | 2022-01-28 | 2023-02-03 | 浙江大学 | Gdf6及其过表达试剂在制备心肌细胞保护剂中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5674844A (en) * | 1991-03-11 | 1997-10-07 | Creative Biomolecules, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
US5906827A (en) * | 1994-06-03 | 1999-05-25 | Creative Biomolecules, Inc. | Matrix for the manufacture of autogenous replacement body parts |
EP0812207B1 (en) * | 1995-03-01 | 2000-11-02 | Stryker Corporation | Morphogen-induced dentine regeneration |
-
1998
- 1998-12-16 WO PCT/US1998/026788 patent/WO1999031136A2/en not_active Application Discontinuation
- 1998-12-16 CA CA002314821A patent/CA2314821A1/en not_active Abandoned
- 1998-12-16 EP EP98964007A patent/EP1040126A2/en not_active Withdrawn
- 1998-12-16 JP JP2000539059A patent/JP2002508173A/ja not_active Withdrawn
- 1998-12-16 AU AU19218/99A patent/AU763488B2/en not_active Ceased
-
2003
- 2003-10-24 AU AU2003257871A patent/AU2003257871A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1040126A2 (en) | 2000-10-04 |
AU763488B2 (en) | 2003-07-24 |
WO1999031136A3 (en) | 1999-08-26 |
AU1921899A (en) | 1999-07-05 |
AU2003257871A1 (en) | 2003-11-20 |
WO1999031136A2 (en) | 1999-06-24 |
JP2002508173A (ja) | 2002-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee | Regulation of muscle mass by myostatin | |
Nakae et al. | Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR | |
Amthor et al. | Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth | |
JP5829193B2 (ja) | Tdf関連化合物およびその類似体 | |
Mayr et al. | Fritz: a secreted frizzled-related protein that inhibits Wnt activity | |
US20090047275A1 (en) | Nell-1 enhanced bone mineralization | |
US20110111505A1 (en) | Genetically engineered cells which express bone morphogenic proteins | |
EP0601129B1 (en) | Morphogenic protein screening method | |
AU743744B2 (en) | Novel morphogen-responsive signal transducer and methods of use thereof | |
KR101008734B1 (ko) | 유사분열촉진 활성을 가진 Bv8 핵산 및 폴리펩티드 | |
Montuenga et al. | Coordinate expression of transforming growth factor-β1 and adrenomedullin in rodent embryogenesis | |
AU763488B2 (en) | Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells | |
JPH11510054A (ja) | モルフォゲンアナログを同定するための方法および組成物 | |
JPH11510387A (ja) | モルフォゲンアナログを同定するための方法および組成物 | |
US5707810A (en) | Method of diagnosing renal tissue damage or disease | |
US6432410B1 (en) | Morphogenic proteins | |
KR100279797B1 (ko) | 세포 주기 조절 조성물 및 그의 사용 방법 | |
CA2371695A1 (en) | Morphogen-induced enhancement of fertility | |
Zimmerman | Inhibition of Smad-mediated activin and TGFβ signaling by calmodulin | |
US20090060988A1 (en) | Nell-1 enhanced bone mineralization | |
Watabe | Molecular mechanisms of Spemann's organizer formation in Xenopus laevis | |
Xiao et al. | ATF4, A Novel Mediator of the Anabolic Actions of PTH on Bone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |
Effective date: 20150710 |